Evidence map›Paper›PMID 36460697›Full record

ArticleScientific reports2022

ResNet-32 and FastAI for diagnoses of ductal carcinoma from 2D tissue slides.

S Phani Praveen, Parvathaneni Naga Srinivasu, Jana Shafi, Marcin Wozniak, Muhammad Fazal Ijaz

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S Phani PraveenDepartment of Computer Science and Engineering, Prasad V Potluri Siddhartha Institute of Technology, Vijayawada, 520007, India.ORCID 0000-0002-7458-5908
Parvathaneni Naga SrinivasuDepartment of Computer Science and Engineering, Prasad V Potluri Siddhartha Institute of Technology, Vijayawada, 520007, India.ORCID 0000-0001-9247-9132
Jana ShafiDepartment of Computer Science, College of Arts and Science, Prince Sattam bin Abdul Aziz University, Wadi Ad-Dawasir, 11991, Saudi Arabia.ORCID 0000-0001-6859-670X
Marcin WozniakFaculty of Applied Mathematics, Silesian University of Technology, 44-100, Gliwice, Poland. marcin.wozniak@polsl.pl.ORCID 0000-0002-9073-5347
Muhammad Fazal IjazDepartment of Mechanical Engineering, Faculty of Engineering and Information Technology, The University of Melbourne, Grattam Street, Parkville, VIC, 3010, Australia. fazal.ijaz@unimelb.edu.au.ORCID 0000-0002-9381-5801

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinoma is a primary source of morbidity in women globally, with metastatic disease accounting for most deaths. Its early discovery and diagnosis may significantly increase the odds of survival. Breast cancer imaging is critical for early identification, clinical staging, management choices, and treatment planning. In the current study, the FastAI technology is used with the ResNet-32 model to precisely identify ductal carcinoma. ResNet-32 is having few layers comparted to majority of its counterparts with almost identical performance. FastAI offers a rapid approximation toward the outcome for deep learning models via GPU acceleration and a faster callback mechanism, which would result in faster execution of the model with lesser code and yield better precision in classifying the tissue slides. Residual Network (ResNet) is proven to handle the vanishing gradient and effective feature learning better. Integration of two computationally efficient technologies has yielded a precision accuracy with reasonable computational efforts. The proposed model has shown considerable efficiency in the evaluating parameters like sensitivity, specificity, accuracy, and F1 Score against the other dominantly used deep learning models. These insights have shown that the proposed approach might assist practitioners in analyzing Breast Cancer (BC) cases appropriately, perhaps saving future complications and death. Clinical and pathological analysis and predictive accuracy have been improved with digital image processing.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastNeoplasms, Second PrimaryAccelerationDisease ProgressionFemaleHumans

Identifiers

PMID36460697
PMCPMC9716161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.